(Q40401867)

20 September 2017

1 reference

title

The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis (English)

1 reference

20 September 2017

1 reference

Pötgens AJ

1

1 reference

20 September 2017

Westphal HR

series ordinal

2

1 reference

20 September 2017

de Waal RM

series ordinal

3

1 reference

20 September 2017

Ruiter DJ

series ordinal

4

1 reference

20 September 2017

publication date

1 February 1995

1 reference

Biological chemistry Hoppe-Seyler

20 September 2017

published in

1 reference

20 September 2017

volume

376

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

57-70

1 reference

Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human microvascular endothelial cells express receptors for platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The heparin-binding (fibroblast) growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Antiangiogenesis as a strategy for antimetastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular attack as a therapeutic strategy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Signalling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

What is the role of angiogenesis in metastasis from cutaneous melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The fibroblast growth factor family: structural and biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

A dual receptor system is required for basic fibroblast growth factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Regulators of Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The ins and outs of fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Basic fibroblast growth factor induces angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Specific binding of vascular permeability factor to endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Endothelial cell regulation by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Recent developments in the cell biology of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Autocrinological role of basic fibroblast growth factor on tube formation of vascular endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular permeability factor (VPF, VEGF) in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Macrophage-derived angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Structure and expression of the human cystatin C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human cystatin, a new protein inhibitor of cysteine proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Immunolocalization of human cystatins in neutrophils and lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Structure and functions of human kininogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Cystatin-like cysteine proteinase inhibitors from human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Mapping of the gene for human cysteine proteinase inhibitor stefin A, STF1, to chromosome 3cen-q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Purification and some characteristics of the human epidermal SH-protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human cystatins in normal and diseased tissues--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Effects of UV, 4-NQO and TPA on gene expression in cultured human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

21 January 2018

HMW and LMW kininogens

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

A single gene for bovine high molecular weight and low molecular weight kininogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Stefins and lysosomal cathepsins B, L and D in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Protein inhibitors of proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Primary structures of bovine liver low molecular weight kininogen precursors and their two mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Evolution of proteins of the cystatin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Occurrence of acid and neutral cysteine proteinase inhibitors in epidermal malignancies: immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Localization of cathepsin H and its inhibitor in the skin and other stratified epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human cysteine-proteinase inhibitors: nucleotide sequence analysis of three members of the cystatin gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The human cystatin C gene (CST3) is a member of the cystatin gene family which is localized on chromosome 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Molecular cloning and sequencing of cDNA for rat cystatin beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Structural organization of the gene encoding rat cystatin β

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

v-Ha-Ras insertion/deletion mutants with reduced protease-inhibitory activity have no transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Cystatin. Amino acid sequence and possible secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Identification of hematoxylin-stainable protein in epidermal keratohyalin granules as phosphorylated cystatin α by protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The human type 2 cystatin gene family consists of eight to nine members, with at least seven genes clustered at a single locus on human chromosome 20

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Molecular characterization and mapping of murine genes encoding three members of the stefin family of cysteine proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

The cystatins: Protein inhibitors of cysteine proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Localization of the human cystatin D gene (CST5) to chromosome 20p11.21 by in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Protein Inhibitors of Cysteine Proteinases. III. Amino-Acid Sequence of Cystatin from Chicken Egg White

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Basic fibroblast growth factor in human pheochromocytoma: A biochemical and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Degradation of a cAMP-binding protein is inhibited by human c-Ha-ras gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1995.376.2.57

10.1515/BCHM3.1995.376.2.57

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference